TickerFacts.

Company research / PROK

Prokidney Corp. (PROK)

Build a valuation ↗↓ Download CSV

SEC name PROKIDNEY CORP. · CIK 0001850270 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Prokidney Corp. reported revenue of $893.0K. Over the twelve months to 2026-06-30, revenue was $818.0K.

Key ratios (year ended 2025-12-31)

n/m
Operating margin
n/m
Net margin
n/m
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-20

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$818.0K$893.0K$76.0K$0$0n/an/a
R&D Expense$130.91M$114.12M$127.67M$106.71M$82.07M$46.26M$21.04M
Operating Income-$177.22M-$165.01M-$183.68M-$151.52M-$153.01M-$55.11M-$27.02M
Depreciation & Amortization$6.85M$6.58M$5.43M$3.85M$3.04M$1.98M$964.0K
EBITDA-$170.37M-$158.43M-$178.24M-$147.67M-$149.97M-$53.13M-$26.06M
Net Income-$165.75M-$151.61M-$163.34M-$135.45M-$148.13M-$55.15M-$26.75M
EPS (Diluted)n/an/an/an/a-$0.23n/an/a
Total Assets$249.02M$335.57M$441.07M$420.55M$518.00M$40.30Mn/a
Total Liabilities$26.18M$34.78M$39.44M$29.22M$13.06M$13.38Mn/a
Shareholders' Equity-$883.53M-$1.01B-$994.95M-$1.10B-$1.10B$26.92M$9.86M
Cash & Equivalents$74.87M$108.54M$99.12M$60.65M$490.25M$20.56Mn/a
Operating Cash Flow-$141.17M-$120.12M-$126.35M-$90.07M-$77.09M-$50.30M-$25.18M
Capital Expenditures$18.57M$15.20M$29.51M$34.20M$1.85M$5.19M$5.46M
Free Cash Flow-$159.73M-$135.31M-$155.86M-$124.27M-$78.94M-$55.49M-$30.64M
Share Repurchasesn/a$0$0$9.50M$0$0n/a
Weighted Average Diluted Sharesn/an/an/an/a61.54Mn/an/a
EPS (Basic)n/an/an/an/a-$0.23n/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView